266 results on '"Aghaee-Bakhtiari, Seyed Hamid"'
Search Results
2. A label-free electrochemical biosensor based on PBA-Au-MXene QD for miR-122 detection in serum samples
3. Miracle drink supplemented with Lactobacillus bulgaricus loaded-chitosan/alginate nanoparticles as a medicinal food for control of MCF7 cancer cells
4. Clinical value and potential circulating of miR-99a as tumor suppressor biomarker in serum of oral squamous cell carcinoma and erosive atrophic lichen planus
5. Inducing apoptosis by using microRNA in radio-resistant prostate cancer: an in-silico study with an in-vitro validation
6. MicroRNA delivery by arginine-rich cell-penetrating peptides: An investigation on expression and the cellular uptake mechanisms
7. Activation of the BMP2/SMAD4 signaling pathway for enhancing articular cartilage regeneration of mesenchymal stem cells utilizing chitosan/alginate nanoparticles on 3D extracellular matrix scaffold
8. Evaluation of the diagnostic role of circulating miR-16, miR-10b, and miR-21 expression in patients with nonalcoholic fatty liver disease
9. Analysis of the therapeutic potential of miR-124 and miR-16 in non-alcoholic fatty liver disease
10. Correction: Melatonin Attenuates Arsenic-Induced Neurotoxicity in Rats through the Regulation of miR-34a/miR-144 in Sirt1/Nrf2 Pathway
11. Design of a rapid electrochemical biosensor based on MXene/Pt/C nanocomposite and DNA/RNA hybridization for the detection of COVID-19
12. Evaluation of osteogenic induction potency of miR-27a-3p in adipose tissue-derived human mesenchymal stem cells (AD-hMSCs)
13. Investigating Efficacy of Three DNA-Aptamers in Targeted Plasmid Delivery to Human Prostate Cancer Cell Lines
14. Serum mir-31-5p is a reliable biomarker in patients with oral squamous cell carcinoma and oral lichen planus
15. MiR-548c-3p through suppressing Tyms and Abcg2 increases the sensitivity of colorectal cancer cells to 5-fluorouracil
16. Deciphering colorectal cancer progression features and prognostic signature by single-cell RNA sequencing pseudotime trajectory analysis
17. A novel electrochemical biosensor based on signal amplification of Au HFGNs/PnBA-MXene nanocomposite for the detection of miRNA-122 as a biomarker of breast cancer
18. A novel regulatory facet for hypertriglyceridemia: The role of microRNAs in the regulation of triglyceride-rich lipoprotein biosynthesis
19. Downregulation of salivary miR‐3928 as a potential biomarker in patients with oral squamous cell carcinoma and oral lichen planus
20. In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis
21. In silico and experimental validation of a new modified arginine-rich cell penetrating peptide for plasmid DNA delivery
22. The redox modulatory effects of SP/NK1R system: Implications for oxidative stress-associated disorders
23. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by In silico Analysis of Differential Gene Expression
24. Exploration of the key genes involved in Non-alcoholic fatty liver disease and possible microRNA therapeutic targets
25. Potential of chitosan/alginate nanoparticles as a non-viral vector for gene delivery: Formulation and optimization using D-optimal design
26. The effect of oral melatonin supplementation on MT-ATP6 gene expression and IVF outcomes in Iranian infertile couples: a nonrandomized controlled trial
27. Web-based tools for miRNA studies analysis
28. Autophagy-related MicroRNAs in chronic lung diseases and lung cancer
29. Dysregulated microRNAs in prostate cancer: In silico prediction and in vitro validation.
30. Systems biology and machine learning approaches identify drug targets in diabetic nephropathy
31. Peptide decoys: a new technology offering therapeutic opportunities for breast cancer
32. Decoy oligodeoxynucleotide technology: an emerging paradigm for breast cancer treatment
33. Impact of curcumin on ferroptosis‐related genes in colorectal cancer: Insights from in‐silico and in‐vitro studies
34. Online Databases and Circular RNAs
35. Harnessing nucleic acid-based therapeutics for atherosclerotic cardiovascular disease: state of the art
36. Chromosomal Instability in Various Generations of Human Mesenchymal Stem Cells Following the Therapeutic Radiation
37. Harnessing the Therapeutic Potential of Antimicrobial Peptides for Cancers: State of the Art
38. Screening and introduction of key cell cycle microRNAs deregulated in colorectal cancer by integrated bioinformatics analysis
39. MiR-1 Variations in Colorectal Cancer: Possible Implementation as a Potential Accessory Biomarker
40. The role of microRNA-induced apoptosis in diverse radioresistant cancers
41. Corrigendum to “A novel regulatory facet for hypertriglyceridemia: The role of microRNAs in the regulation of triglyceride-rich lipoprotein biosynthesis” [Prog Lipid Res. 2023 Jan;89:101197. doi: 10.1016/j.plipres.2022.101197]
42. miRandb: A Metadatabase of Online Resources of miRNA and miRNA Targets
43. Chromosomal instability in various generations of human mesenchymal stem cells following the therapeutic radiation doses
44. Melatonin ameliorates arsenic‐induced cardiotoxicity through the regulation of the Sirt1/Nrf2 pathway in rats
45. Identification of microRNAs with therapeutic potentials on prostate cancer drug targets: In-silico prediction and In-vitro validation
46. Evaluation of osteogenic induction potency of miR-27a-3p in adipose tissue-derived human mesenchymal stem cells (AD-hMSCs)
47. Application of MXene in the diagnosis and treatment of breast cancer: A critical overview
48. Investigating Efficacy of Three DNA-Aptamers in Targeted Plasmid Delivery to Human Prostate Cancer Cell Lines
49. Potential diagnostic role of salivary miR-let-7a-5p as a biomarker in oral squamous cell carcinoma and oral lichen planus patients: A research article
50. miR ‐27 and miR ‐124 target AR coregulators in prostate cancer: Bioinformatics and in vitro analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.